Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemic
Volume: 43, Pages: 102222 - 102222
Published: Aug 1, 2020
Abstract
Dear Editor, We read with great interest the recent reports of confirmed or possible COVID-19 infection in multiple sclerosis (MS) patients treated with anti-CD20 monoclonal antibodies which were recently published in Multiple Sclerosis and Related Disorders. (Giovannoni, 2020Giovannoni G Anti-CD20 immunosuppressive disease-modifying therapies and COVID-19.Mult. Scler. Relat. Disord. 2020; 41Abstract Full Text Full Text PDF Scopus (38) Google...
Paper Details
Title
Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemic
Published Date
Aug 1, 2020
Volume
43
Pages
102222 - 102222
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History